+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Solutions Market by Product Type, End User, Application, Distribution Channel, Packaging Type - Global Forecast to 2030- Product Image
Intravenous Solutions Market by Product Type, End User, Application, Distribution Channel, Packaging Type - Global Forecast to 2030- Product Image
Sale

Intravenous Solutions Market by Product Type, End User, Application, Distribution Channel, Packaging Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454935
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare executives face a rapidly shifting intravenous solutions landscape, shaped by evolving patient needs and regulatory demands. As infusion therapies become central to acute, ambulatory, and home care, stakeholders require clear intelligence on product innovation, market forces, and resilience strategies to inform critical investment and procurement decisions.

Market Snapshot: Intravenous Solutions Market

The Intravenous Solutions Market grew from USD 14.99 billion in 2024 to USD 16.38 billion in 2025 and is projected to reach USD 25.40 billion by 2030, reflecting a CAGR of 9.18%. Growth is driven by precision care requirements, increased acute and chronic care utilization, and expanding adoption of infusion therapies outside traditional hospital settings. These dynamics are accelerating product diversification, operational investment, and supply chain adaptation among key suppliers and care providers.

Scope & Segmentation

This research delivers an executive-level lens on market structure and growth drivers, with broad segmentation across products, uses, distribution, packaging, and global territories.

  • Product Types: Albumin, synthetic colloids, balanced crystalloid solutions, and normal saline.
  • End Users: Ambulatory care centers, home healthcare providers, and hospitals.
  • Applications: Critical care, emergency/intervention, nutritional support, and use in surgical procedures.
  • Distribution Channels: Hospital pharmacies (centralized supply), online pharmacies (home and outpatient), and retail points (outpatient clinic support).
  • Packaging types: Bottles (glass/plastic), concentrates, and pre-mixed bags for rapid deployment and reduced storage.
  • Geographic Coverage: Regions analyzed include Americas (notably the US and major Latin American markets), Europe/Middle East/Africa, and Asia-Pacific (with focus on China, India, and key Southeast Asian economies).
  • Leading Companies Profiled: Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, Grifols S.A., ICU Medical, Inc., Pfizer Inc., Terumo Corporation, Laboratoires Aguettant S.A., Macopharma S.A.S., and Nipro Corporation.

Key Takeaways

  • Infusion therapy is transitioning from commodity solutions toward specialized, quality-assured, and patient-centered formulations to meet rising care complexities and regulatory scrutiny.
  • Demand softens traditional hospital focus in favor of outpatient and home-based infusion, driving product format innovations and user-friendly delivery systems.
  • Product development increasingly aligns to personalized fluid therapy, with modular manufacturing enabling agile responses to small-batch and tailored solution demands.
  • Regional differences in healthcare capacity, policy, and reimbursement highlight the importance of tailored strategies for local supply and compliance.
  • Competitive advantage is shifting toward digitally integrated devices, sustainable packaging, and alliances that accelerate regulatory approval and access to procurement channels.

Tariff Impact: Navigating New Cost Pressures

US tariffs introduced in 2025 on imported infusion solution components have altered input costs and procurement strategies across health systems. Several providers have shifted to domestically sourced concentrations and packaging where possible, though local production capacity remains constrained in some cases. Downstream effects include a push for diversified supplier portfolios, new long-term contracts, and investments in US-based manufacturing to contain cost volatility and increase resilience. Global players are reassessing production locations, while collaborative partnerships between buyers and manufacturers are strengthening supply chain continuity.

Methodology & Data Sources

Findings are based on mixed-methods research, combining secondary analysis of peer-reviewed studies, regulatory filings, white papers, and patent data with direct interviews among hospital procurement, senior pharmacy leaders, and home infusion specialists. Qualitative insight from expert panels further validated strategic trends and operational themes. All information was triangulated and reviewed for rigor and accuracy.

Why This Report Matters

  • Provides senior stakeholders with actionable market insight for informed product, sourcing, and investment decisions in a complex infusion therapy environment.
  • Equips healthcare organizations with strategic perspectives on technology adoption, regulatory trends, and cost-mitigation measures amid evolving global market forces.

Conclusion

As technological advances and new regulatory dynamics reshape the intravenous solutions sector, decision-makers need an integrated view of market shifts to adapt strategies, sustain operational excellence, and capture emerging growth. This report supports forward-looking leadership in navigating rapid change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intravenous Solutions Market, by Product Type
8.1. Introduction
8.2. Colloids
8.2.1. Albumin
8.2.2. Synthetic Colloids
8.3. Crystalloids
8.3.1. Balanced Solutions
8.3.2. Normal Saline
9. Intravenous Solutions Market, by End User
9.1. Introduction
9.2. Ambulatory Care
9.3. Home Healthcare Providers
9.4. Hospitals
10. Intravenous Solutions Market, by Application
10.1. Introduction
10.2. Critical Care
10.3. Emergency Care
10.4. Nutritional Support
10.5. Surgical Procedures
11. Intravenous Solutions Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Intravenous Solutions Market, by Packaging Type
12.1. Introduction
12.2. Bottles
12.3. Concentrates
12.4. Pre-Mixed Bags
13. Americas Intravenous Solutions Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Intravenous Solutions Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Intravenous Solutions Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Baxter International Inc.
16.3.2. Fresenius Kabi AG
16.3.3. B. Braun Melsungen AG
16.3.4. Grifols, S.A.
16.3.5. ICU Medical, Inc.
16.3.6. Pfizer Inc.
16.3.7. Terumo Corporation
16.3.8. Laboratoires Aguettant S.A.
16.3.9. Macopharma S.A.S.
16.3.10. Nipro Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INTRAVENOUS SOLUTIONS MARKET MULTI-CURRENCY
FIGURE 2. INTRAVENOUS SOLUTIONS MARKET MULTI-LANGUAGE
FIGURE 3. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SYNTHETIC COLLOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY BALANCED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRE-MIXED BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 50. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 51. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 58. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 91. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 93. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 98. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 100. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 101. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 112. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 114. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 115. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 119. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 121. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 122. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 147. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 149. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 150. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 161. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 163. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 164. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 171. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 189. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 196. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 198. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 199. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 213. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 217. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 219. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 220. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 239. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 241. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 242. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 246. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 248. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 249. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 253. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 255. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 256. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 281. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 284. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COLLOIDS, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY CRYSTALLOIDS, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 323. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 324. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Intravenous Solutions market report include:
  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Terumo Corporation
  • Laboratoires Aguettant S.A.
  • Macopharma S.A.S.
  • Nipro Corporation

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.4 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Intravenous (IV) Solutions - Global Strategic Business Report - Product Image

Intravenous (IV) Solutions - Global Strategic Business Report

  • Report
  • 487 Pages
  • Global
From
Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033 - Product Image

Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033

  • Report
  • 144 Pages
  • Global
From
Intravenous (IV) Solutions Market 2024-2028 - Product Image

Intravenous (IV) Solutions Market 2024-2028

  • Report
  • 157 Pages
  • Global
From
Intravenous Solutions Market Report 2025 - Product Image

Intravenous Solutions Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Intravenous Solution Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Intravenous Solution Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the IV Solution Market

The IV Solution market is a segment of the medical device industry that focuses on the production and distribution of intravenous solutions. These solutions are used to deliver medications, nutrients, and other fluids directly into a patient's bloodstream. IV solutions are typically packaged in bags, bottles, or syringes and are available in a variety of concentrations and sizes. They are used in a variety of medical settings, including hospitals, clinics, and home care. The IV Solution market is highly competitive, with a wide range of products available from a variety of manufacturers. Companies in the market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, ICU Medical, and Terumo Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.